MI891 is a highly selective PXR antagonist ( IC 50 = 3.76 μM, K d = 1.7 μM) and inverse agonist ( IC 50 = 6.1 μM). MI891 selectively disrupts the interaction between PXR and its coactivator SRC1. MI891 effectively inhibits Rifampicin ( HY-B0272 )-induced PXR activation. MI891 is useful for the study of metabolic diseases and other diseases .
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Pregnane X Receptor (PXR) | Products > Signaling Pathways > Cytochrome P450
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.